PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
31.23%
Net income growth 1.25-1.5x TSM's 22.73%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
-2.09%
Negative yoy D&A while TSM is 0.40%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
114.63%
Deferred tax of 114.63% while TSM is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
2.88%
Less SBC growth vs. TSM's 1431.12%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-831.03%
Both reduce yoy usage, with TSM at -60.60%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-608.55%
Both yoy AR lines negative, with TSM at -35.98%. Martin Whitman would suspect an overall sector lean approach or softer demand.
52.40%
Inventory growth well above TSM's 35.44%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-6.67%
Both negative yoy AP, with TSM at -71.71%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-79.04%
Both reduce yoy usage, with TSM at -64.37%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-700.00%
Negative yoy while TSM is 150.16%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.34%
Both yoy CFO lines are negative, with TSM at -1.59%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-5.30%
Both yoy lines negative, with TSM at -11.53%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-94.12%
Negative yoy acquisition while TSM stands at 422.05%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
31.18%
Purchases well above TSM's 12.85%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
-4.22%
Both yoy lines are negative, with TSM at -46.67%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
94.12%
Growth well above TSM's 159.94%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
59.35%
We have mild expansions while TSM is negative at -17.42%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment similar to TSM's 99.66%. Walter Schloss sees parallel liability management or similar free cash flow availability.
No Data
No Data available this quarter, please select a different quarter.
-111.06%
We cut yoy buybacks while TSM is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.